• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小檗碱联合氟康唑对氟康唑耐药菌株的作用机制研究 。 需注意,原文中“of.”后面内容缺失,翻译是基于现有完整部分进行的。

Study on the mechanisms of action of berberine combined with fluconazole against fluconazole-resistant strains of .

作者信息

Kai-Su Pan, Hong Luo, Dong-Yan Zheng, Yan-Qing Zheng, Andrianopoulos Alex, Latgé Jean-Paul, Cun-Wei Cao

机构信息

Department of Dermatology and Venereology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Guangxi Key Laboratory of Mycosis Research and Prevention, Nanning, China.

出版信息

Front Microbiol. 2022 Nov 14;13:1033211. doi: 10.3389/fmicb.2022.1033211. eCollection 2022.

DOI:10.3389/fmicb.2022.1033211
PMID:36452929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9704026/
Abstract

() is a thermally dimorphic fungus that can cause opportunistic systemic mycoses. Our previous study demonstrated that concomitant use of berberine (BBR) and fluconazole (FLC) showed a synergistic action against FLC-resistant (B4) . In this paper, we tried to figure out the antifungal mechanisms of BBR and FLC in FLC-resistant. In the microdilution test, the minimum inhibitory concentration (MIC) of FLC was 256 μg/ml before FLC and BBR combination, and was 8 μg/ml after combination, the partial inhibitory concentration index (FICI) of B4 was 0.28. After the treatments of BBR and FLC, the studies revealed that (i) increase reactive oxygen species (ROS), (ii) reduce ergosterol content, (iii) destroy the integrity of cell wall and membrane, (iv) decrease the expression of genes , , , and however and change are not obvious. These results confirmed that BBR has antifungal effect on , and the combination with FLC can restore the susceptibility of FLC-resistant strains to FLC, and the reduction of ergosterol content and the down-regulation of gene expression of , and are the mechanisms of the antifungal effect after the combination, which provides a theoretical basis for the application of BBR in the treatment of Talaromycosis and opens up new ideas for treatment of Talaromycosis.

摘要

(某菌)是一种可引起机会性系统性真菌病的热双态真菌。我们之前的研究表明,黄连素(BBR)和氟康唑(FLC)联合使用对耐氟康唑的(B4菌株)具有协同作用。在本文中,我们试图弄清楚BBR和FLC对耐氟康唑菌株的抗真菌机制。在微量稀释试验中,FLC与BBR联合使用前,FLC的最低抑菌浓度(MIC)为256μg/ml,联合使用后为8μg/ml,B4菌株的部分抑菌浓度指数(FICI)为0.28。经过BBR和FLC处理后,研究发现:(i)增加活性氧(ROS);(ii)降低麦角甾醇含量;(iii)破坏细胞壁和细胞膜的完整性;(iv)降低基因、、、和的表达,然而和的变化不明显。这些结果证实,BBR对(该菌)有抗真菌作用,与FLC联合使用可恢复耐氟康唑菌株对FLC的敏感性,麦角甾醇含量的降低以及、和基因表达的下调是联合使用后抗真菌作用的机制,这为BBR在治疗(某菌病)中的应用提供了理论依据,并为(某菌病)的治疗开辟了新思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/bcd974c19bfa/fmicb-13-1033211-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/f46c2085a74f/fmicb-13-1033211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/d0128998137e/fmicb-13-1033211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/8142dfddbb21/fmicb-13-1033211-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/f09c02e0595f/fmicb-13-1033211-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/9e751792e307/fmicb-13-1033211-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/de3caf9a37a0/fmicb-13-1033211-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/bcd974c19bfa/fmicb-13-1033211-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/f46c2085a74f/fmicb-13-1033211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/d0128998137e/fmicb-13-1033211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/8142dfddbb21/fmicb-13-1033211-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/f09c02e0595f/fmicb-13-1033211-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/9e751792e307/fmicb-13-1033211-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/de3caf9a37a0/fmicb-13-1033211-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c339/9704026/bcd974c19bfa/fmicb-13-1033211-g007.jpg

相似文献

1
Study on the mechanisms of action of berberine combined with fluconazole against fluconazole-resistant strains of .小檗碱联合氟康唑对氟康唑耐药菌株的作用机制研究 。 需注意,原文中“of.”后面内容缺失,翻译是基于现有完整部分进行的。
Front Microbiol. 2022 Nov 14;13:1033211. doi: 10.3389/fmicb.2022.1033211. eCollection 2022.
2
Antiproliferation of Berberine in Combination with Fluconazole from the Perspectives of Reactive Oxygen Species, Ergosterol and Drug Efflux in a Fluconazole-Resistant Isolate.从活性氧、麦角甾醇及药物外排角度探讨小檗碱联合氟康唑对氟康唑耐药菌株的抗增殖作用
Front Microbiol. 2016 Sep 23;7:1516. doi: 10.3389/fmicb.2016.01516. eCollection 2016.
3
Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant Isolates.麦角甾醇是小檗碱耐受所必需的,这为氟康唑和小檗碱联合治疗氟康唑耐药分离株提供了协同作用。
Front Cell Infect Microbiol. 2017 Nov 29;7:491. doi: 10.3389/fcimb.2017.00491. eCollection 2017.
4
Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates.小檗碱介导临床氟康唑耐药热带念珠菌分离株对氟康唑敏感性增强的机制。
Biomed Pharmacother. 2017 Sep;93:709-712. doi: 10.1016/j.biopha.2017.06.106. Epub 2017 Jul 9.
5
Fluconazole inhibits cellular ergosterol synthesis to confer synergism with berberine against yeast cells.氟康唑通过抑制细胞麦角固醇合成来与小檗碱协同作用,对抗酵母菌。
J Glob Antimicrob Resist. 2018 Jun;13:125-130. doi: 10.1016/j.jgar.2017.12.011. Epub 2017 Dec 26.
6
Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation.蛋白质组学分析揭示了氟康唑和小檗碱联合抗氟康唑耐药白念珠菌的协同作用机制:内源性 ROS 增强。
J Proteome Res. 2009 Nov;8(11):5296-304. doi: 10.1021/pr9005074.
7
In Vitro Susceptibility of Berberine Combined with Antifungal Agents Against the Yeast Form of Talaromyces marneffei.贝母素联合抗真菌药物对马尔尼菲篮状菌酵母相的体外药敏研究。
Mycopathologia. 2019 Apr;184(2):295-301. doi: 10.1007/s11046-019-00325-y. Epub 2019 Feb 25.
8
Synergistic antifungal activity of berberine derivative B-7b and fluconazole.小檗碱衍生物B-7b与氟康唑的协同抗真菌活性。
PLoS One. 2015 May 19;10(5):e0126393. doi: 10.1371/journal.pone.0126393. eCollection 2015.
9
Fluconazole assists berberine to kill fluconazole-resistant Candida albicans.氟康唑协助黄连素杀死耐氟康唑的白色念珠菌。
Antimicrob Agents Chemother. 2013 Dec;57(12):6016-27. doi: 10.1128/AAC.00499-13. Epub 2013 Sep 23.
10
In Vitro Activity of Berberine Alone and in Combination with Antifungal Drugs Against Planktonic Forms and Biofilms of Trichosporon Asahii.单独使用小檗碱和联合使用抗真菌药物对阿萨希丝孢酵母浮游形式和生物膜的体外活性。
Mycopathologia. 2017 Oct;182(9-10):829-837. doi: 10.1007/s11046-017-0119-7. Epub 2017 Jan 31.

引用本文的文献

1
Inhibitory effects of berberine on fungal growth, biofilm formation, virulence, and drug resistance as an antifungal drug and adjuvant with prospects for future applications.黄连素作为一种抗真菌药物及佐剂,对真菌生长、生物膜形成、毒力和耐药性的抑制作用及未来应用前景。
World J Microbiol Biotechnol. 2024 Dec 18;41(1):5. doi: 10.1007/s11274-024-04223-4.
2
Diagnosis of Human Endemic Mycoses Caused by Thermally Dimorphic Fungi: From Classical to Molecular Methods.由双相真菌引起的人类地方性真菌病的诊断:从经典方法到分子方法
J Fungi (Basel). 2024 Sep 6;10(9):637. doi: 10.3390/jof10090637.
3
New Polyene Macrolide Compounds from Mangrove-Derived Strain GXIMD 06359: Isolation, Antifungal Activity, and Mechanism against .

本文引用的文献

1
Emergence of Triazole Resistance in Exposed to Paclobutrazol.暴露于多效唑中的三唑类耐药性的出现。
J Agric Food Chem. 2021 Dec 29;69(51):15538-15543. doi: 10.1021/acs.jafc.1c05396. Epub 2021 Dec 17.
2
Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology.罕见霉菌感染诊断与管理全球指南:欧洲医学真菌学联合会与国际人类与动物真菌学会及美国微生物学会合作发起
Lancet Infect Dis. 2021 Aug;21(8):e246-e257. doi: 10.1016/S1473-3099(20)30784-2. Epub 2021 Feb 16.
3
新型多烯大环内酯化合物来自红树林来源菌株 GXIMD 06359: 分离、抗真菌活性及对. 的作用机制
Mar Drugs. 2024 Jan 8;22(1):38. doi: 10.3390/md22010038.
In Vitro Susceptibility of Berberine Combined with Antifungal Agents Against the Yeast Form of Talaromyces marneffei.
贝母素联合抗真菌药物对马尔尼菲篮状菌酵母相的体外药敏研究。
Mycopathologia. 2019 Apr;184(2):295-301. doi: 10.1007/s11046-019-00325-y. Epub 2019 Feb 25.
4
Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates.小檗碱介导临床氟康唑耐药热带念珠菌分离株对氟康唑敏感性增强的机制。
Biomed Pharmacother. 2017 Sep;93:709-712. doi: 10.1016/j.biopha.2017.06.106. Epub 2017 Jul 9.
5
A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis.伊曲康唑或两性霉素 B 治疗 HIV 相关足放线病菌病的试验。
N Engl J Med. 2017 Jun 15;376(24):2329-2340. doi: 10.1056/NEJMoa1613306.
6
Administration of Voriconazole in Disseminated Talaromyces (Penicillium) Marneffei Infection: A Retrospective Study.伏立康唑治疗播散性马尔尼菲篮状菌(青霉菌)感染的回顾性研究。
Mycopathologia. 2017 Jun;182(5-6):569-575. doi: 10.1007/s11046-016-0107-3. Epub 2017 Jan 20.
7
Antiproliferation of Berberine in Combination with Fluconazole from the Perspectives of Reactive Oxygen Species, Ergosterol and Drug Efflux in a Fluconazole-Resistant Isolate.从活性氧、麦角甾醇及药物外排角度探讨小檗碱联合氟康唑对氟康唑耐药菌株的抗增殖作用
Front Microbiol. 2016 Sep 23;7:1516. doi: 10.3389/fmicb.2016.01516. eCollection 2016.
8
Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Fungi.真菌中唑类耐药机制的流行病学和基因组概况
Front Microbiol. 2016 Sep 21;7:1382. doi: 10.3389/fmicb.2016.01382. eCollection 2016.
9
A Retrospective Analysis of 7 Human Immunodeficiency Virus-Negative Infants Infected by Penicillium marneffei.7例马尔尼菲青霉感染的人类免疫缺陷病毒阴性婴儿的回顾性分析
Medicine (Baltimore). 2015 Aug;94(34):e1439. doi: 10.1097/MD.0000000000001439.
10
Medically important fungi respond to azole drugs: an update.具有医学重要性的真菌对唑类药物的反应:最新进展
Future Microbiol. 2015;10(8):1355-73. doi: 10.2217/FMB.15.47. Epub 2015 Aug 3.